Rocket Lab (NASDAQ:RKLB) Stock Falls 6.6% – Should You Sell?

Rocket Lab Corporation (NASDAQ:RKLB) shares fell 6.6% on Thursday. The company traded as low as $49.69 and last traded at $55.25. Approximately 47,868,544 shares changed hands during mid-day trading, an increase of 107% from the average session volume of 23,094,160 shares. The stock had previously closed at $59.18.

Key Headlines Impacting Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Rocket Lab retains approximately $2.4 billion in backlog, alongside its established Electron launch business, satellite systems operations and defense-related contracts. Analysts argue these businesses provide support while Neutron development continues. Rocket Lab Still Has a $2.4B Backlog While Neutron Waits
• Positive Sentiment: Some analysts remain constructive: TD Cowen reaffirmed a Buy rating with a $90 price target, while Roth Capital maintained Buy at $110. Cantor Fitzgerald also maintained its rating with a $122 target, suggesting substantial long-term upside if execution improves. Stay Cool, Says Analyst About Rocket Lab Stock
• Neutral Sentiment: Rocket Lab said Neutron’s first launch is now expected in 2027 rather than late 2026. The company plans to complete additional testing in the first quarter before setting a specific launch date, making the timing uncertain but allowing more time to address reliability issues. Rocket Lab Provides Update on Neutron Development and Adjusts Target Launch Timing
• Negative Sentiment: The delay was triggered by a manufacturing flaw in a carbon-composite propellant tank dome on Neutron’s first stage. The issue follows a tank rupture during testing in January, raising concerns about development execution, additional costs and the company’s ability to compete with SpaceX in medium-lift launches. Rocket Lab pushes Neutron rocket’s debut flight to 2027
• Negative Sentiment: KeyBanc reduced its price target to $100, and Clear Street set a $105 target, reflecting heightened execution risk. Investors are also weighing recent equity issuance for the planned Iridium acquisition, insider selling and lower projected gross margins, which could increase dilution and cash-burn concerns.
• Negative Sentiment: A broader selloff in technology and semiconductor stocks contributed to risk-off sentiment, but the Neutron setback was the primary company-specific catalyst behind RKLB’s decline.

Analyst Ratings Changes

A number of analysts have weighed in on RKLB shares. Citigroup initiated coverage on shares of Rocket Lab in a report on Thursday, October 1st. They issued a “buy” rating and a $105.00 price target for the company. Wall Street Zen cut Rocket Lab from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. Morgan Stanley reaffirmed an “overweight” rating on shares of Rocket Lab in a research report on Wednesday, July 8th. Barclays initiated coverage on Rocket Lab in a report on Friday, October 9th. They set an “overweight” rating and a $85.00 price target for the company. Finally, Needham & Company LLC reaffirmed a “buy” rating on shares of Rocket Lab in a report on Tuesday, August 11th. Four research analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $104.05.

Rocket Lab Stock Down 6.6%

The stock has a market cap of $33.06 billion, a price-to-earnings ratio of -204.62 and a beta of 2.93. The stock has a 50 day simple moving average of $69.91 and a 200 day simple moving average of $84.33. The company has a quick ratio of 4.98, a current ratio of 5.48 and a debt-to-equity ratio of 0.01.

Rocket Lab (NASDAQ:RKLB) last released its quarterly earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.02). The firm had revenue of $234.07 million for the quarter, compared to the consensus estimate of $231.62 million. Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. As a group, analysts expect that Rocket Lab Corporation will post -0.20 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, CFO Adam Spice sold 140,157 shares of the company’s stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $70.82, for a total value of $9,925,918.74. Following the transaction, the chief financial officer owned 1,155,967 shares of the company’s stock, valued at approximately $81,865,582.94. This represents a 10.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Marvin Clevenger sold 15,051 shares of the business’s stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $69.63, for a total value of $1,048,001.13. Following the transaction, the insider directly owned 458,924 shares of the company’s stock, valued at $31,954,878.12. The trade was a 3.18% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 400,749 shares of company stock worth $26,964,474. Company insiders own 8.40% of the company’s stock.

Hedge Funds Weigh In On Rocket Lab

A number of institutional investors and hedge funds have recently made changes to their positions in RKLB. Assenagon Asset Management S.A. boosted its position in shares of Rocket Lab by 24.2% during the third quarter. Assenagon Asset Management S.A. now owns 21,831 shares of the rocket manufacturer’s stock worth $1,521,000 after acquiring an additional 4,251 shares during the last quarter. Formuepleje A S purchased a new position in shares of Rocket Lab in the 3rd quarter worth approximately $425,000. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new position in shares of Rocket Lab in the third quarter worth $446,000. HBW Advisory Services LLC grew its position in Rocket Lab by 2.4% during the 3rd quarter. HBW Advisory Services LLC now owns 7,816 shares of the rocket manufacturer’s stock worth $545,000 after purchasing an additional 182 shares during the period. Finally, Tempus Wealth Planning LLC increased its holdings in Rocket Lab by 3.0% in the third quarter. Tempus Wealth Planning LLC now owns 26,402 shares of the rocket manufacturer’s stock valued at $1,840,000 after buying an additional 768 shares in the last quarter. Hedge funds and other institutional investors own 71.78% of the company’s stock.

Rocket Lab Company Profile

Rocket Lab USA, Inc is a space and launch company that provides launch services, spacecraft, satellite components and other space systems for commercial, civil and national-security customers. The company designs and manufactures many of its products in-house, supporting missions from initial spacecraft development through launch and on-orbit operations.

Rocket Lab’s primary launch vehicle is Electron, a small-lift rocket designed to place satellites into low Earth orbit. The company also operates the HASTE suborbital test platform for hypersonic and other advanced aerospace technologies and is developing Neutron, a larger reusable rocket intended to serve commercial and government missions.